Lowering Expectations: Glucocorticoid Tapering Among Veterans With Rheumatoid Arthritis Achieving Low Disease Activity on Stable Biologic Therapy.
Beth I WallaceBryant R EnglandJoshua F BakerJorge RojasBrian C SauerPunyasha RoulGary A KunkelTawnie J BraatenAlison PetroTed R MikulsGrant W CannonPublished in: ACR open rheumatology (2023)
In a real-world RA cohort of chronic glucocorticoid users in LDA, half successfully tapered and a third discontinued prednisone within 6 months of initiating a new b/tsDMARD. Claims-based algorithms of glucocorticoid tapering and discontinuation may be useful to evaluate predictors of tapering in administrative data sets.
Keyphrases
- rheumatoid arthritis
- disease activity
- rheumatoid arthritis patients
- ankylosing spondylitis
- systemic lupus erythematosus
- juvenile idiopathic arthritis
- machine learning
- interstitial lung disease
- health insurance
- electronic health record
- bone marrow
- smoking cessation
- cell therapy
- drug induced
- replacement therapy
- systemic sclerosis